XML 19 R12.htm IDEA: XBRL DOCUMENT v3.25.2
Cash, Cash Equivalents and Investments
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Cash, Cash Equivalents and Investments

Note 4. Cash, Cash Equivalents and Investments

The following tables categorize the fair values of cash, cash equivalents and investments measured at fair value on a recurring basis on our balance sheets (in thousands):

 

 

June 30, 2025

 

 

December 31, 2024

 

Cash and cash equivalents:

 

 

 

 

 

 

Cash

 

$

827

 

$

2,510

 

Money market funds

 

 

15,999

 

 

3,702

 

Total cash and cash equivalents

 

$

16,826

 

$

6,212

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

Government and agency notes

 

 

17,882

 

 

34,572

 

Total short-term investments

 

$

17,882

 

$

34,572

 

 

The Company's investments are classified as available-for-sale securities. As of June 30, 2025, the weighted average remaining contractual maturities of available-for-sale securities was approximately 2 months. The unrealized gain (loss) activity related to the Company’s available-for-sale securities is included in the Company’s accumulated other comprehensive income. There were no significant realized gains or losses recognized on the sale or maturity of available-for-sale securities for the three and six months ended June 30, 2025 and 2024, and as a result, the Company did not reclassify any amounts out of accumulated other comprehensive income. Based on the Company’s review of its available-for-sale securities, the Company has no available-for-sale securities in loss positions as of June 30, 2025. No other-than-temporary impairments on these securities were recognized for the three and six months ended June 30, 2025 and 2024.

The Company periodically assesses its investment in available-for-sale securities for impairment losses and credit losses. The amount of credit losses is determined by comparing the difference between the present value of future cash flows expected to be collected on these securities and the amortized cost. Factors considered in assessing credit losses include the position in the capital structure, vintage and amount of collateral, delinquency rates, current credit support, and geographic concentration. There have been no impairments or credit losses related to available-for-sale securities for the three and six months ended June 30, 2025 and 2024.

For available-for-sale debt securities in an unrealized loss position, the Company first assesses whether it intends to sell, or it is more likely than not that it will be required to sell the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security’s amortized cost basis is written down to fair value and recognized in interest and

other income, net in the statement of operations and comprehensive loss. If neither criteria is met, the Company evaluates whether the decline in fair value is related to credit-related factors or other factors. In making this assessment, management considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security, among other factors. Credit-related impairment losses, limited by the amount that the fair value is less than the amortized cost basis, are recorded through an allowance for credit losses in interest and other income, net.

Any unrealized losses from declines in fair value below the amortized cost basis as a result of non-credit factors are recognized in accumulated other comprehensive income, net of tax as a separate component of stockholders’ equity, along with unrealized gains. Realized gains and losses and declines in fair value, if any, on available-for-sale securities are included in interest and other income, net in the statement of operations and comprehensive loss.

For purposes of identifying and measuring credit-related impairments, the Company’s policy is to exclude applicable accrued interest from both the fair value and amortized cost basis of the related security. The Company has elected to write-off uncollectible accrued interest receivable balances in a timely manner, which is defined by the Company as when interest due becomes 90 days delinquent. The accrued interest write-off will be recorded by reversing interest income. Accrued interest receivable is recorded in other current assets on the balance sheets.

The following table summarizes the available-for-sale securities (in thousands):

 

 

Fair Value Measurements as of June 30, 2025

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

Money market funds

 

$

15,999

 

$

 

$

 

$

15,999

 

Government and agency notes

 

 

17,883

 

 

0

 

 

(1

)

 

17,882

 

Total cash equivalents and investments

 

$

33,882

 

$

0

 

$

(1

)

$

33,881

 

 

 

 

 

 

 

 

 

 

 

 

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents (original maturities within 90 days)

 

 

 

 

 

 

 

 

 

 

$

15,999

 

Short-term investments (maturities within one year)

 

 

 

 

 

 

 

 

 

 

 

17,882

 

Total cash equivalents and investments

 

 

 

 

 

 

 

 

 

 

$

33,881

 

 

 

Fair Value Measurements as of December 31, 2024

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair
Value

 

Money market funds

 

$

3,702

 

 

$

 

 

$

 

 

$

3,702

 

Government and agency notes

 

 

34,503

 

 

 

69

 

 

 

 

 

 

34,572

 

Total cash equivalents and investments

 

$

38,205

 

 

$

69

 

 

$

 

 

$

38,274

 

 

 

 

 

 

 

 

 

 

 

 

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents (original maturities within 90 days)

 

 

 

 

 

 

 

 

 

 

$

3,702

 

Short-term investments (maturities within one year)

 

 

 

 

 

 

 

 

 

 

 

34,572

 

Total

 

 

 

 

 

 

 

 

 

 

$

38,274